Form 4: Annovis Bio Director Boosts Stake with $190K Stock Purchase

Annovis Bio Director Michael B Hoffman acquired 45,000 shares of common stock for approximately $190,000, signaling confidence in the company.

Summary

• Michael B Hoffman, a Director of Annovis Bio, Inc. (ANVS), acquired a total of 45,000 shares of common stock.
• The transactions occurred on December 8, 2025, and were executed under a Rule 10b5-1(c) plan.
• The first purchase involved 30,000 shares at a price of $4.3398 per share.
• The second purchase involved 15,000 shares at a price of $4.24 per share.
• Following these transactions, Michael B Hoffman directly beneficially owns 2,574,739 shares of common stock.
• Additionally, 223,357 shares are indirectly beneficially owned through The 2018 Jane and Michael Hoffman Descendants Trust, over which Mr. Hoffman has voting and investment power.

Sentiment

Score: 7

Explanation: The significant stock purchase by a director, especially under a pre-planned Rule 10b5-1 arrangement, indicates strong confidence in the company's future performance and current valuation, which is generally a positive signal for investors.

Positives

• A director's significant purchase of company stock signals strong confidence in the company's future prospects and current valuation.
• The transactions were executed under a Rule 10b5-1 plan, indicating a pre-planned investment strategy rather than a reactive decision.

Future Outlook

NA

Industry Context

Insider buying, particularly from a director, is often viewed by the market as a positive indicator, suggesting that those closest to the company believe its stock is undervalued or poised for future growth, potentially outperforming peers.

Related Party Transactions

• Michael B Hoffman indirectly beneficially owns 223,357 shares through The 2018 Jane and Michael Hoffman Descendants Trust, over which he has voting and investment power.

Stakeholder Impact

• Shareholders may interpret the director's stock purchase as a positive signal, potentially increasing investor confidence and demand for the company's stock.

Key Dates

Recommendation

A director's substantial open-market purchase of company stock, particularly when executed under a Rule 10b5-1 plan, typically signals strong conviction in the company's intrinsic value and future growth prospects at the current share price. This insider confidence often precedes positive developments or a re-evaluation by the broader market, making it a compelling signal for a 'buy' recommendation.

Keywords

Annovis Bio, ANVS, Michael B Hoffman, insider trading, Form 4, stock purchase, director, beneficial ownership, Rule 10b5-1